Phase 2 Type 2 Diabetes Clinical Trials
24 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–20 of 24 trials
Recruiting
Phase 2
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Type 2 DiabetesCortisol Excess
Sparrow Pharmaceuticals1,500 enrolled46 locationsNCT07296484
Recruiting
Phase 2
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
Type 2 Diabetes Mellitus
Hoffmann-La Roche240 enrolled51 locationsNCT07112872
Recruiting
Phase 2
A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
Type 2 Diabetes Mellitus (T2DM)
Alnylam Pharmaceuticals40 enrolled1 locationNCT07465224
Recruiting
Phase 2
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Type 2 Diabetes
Eli Lilly and Company240 enrolled56 locationsNCT06897475
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
Type 2 Diabetes Mellitus (T2DM)Obese or Overweight Healthy Volunteers
Alnylam Pharmaceuticals144 enrolled2 locationsNCT06845202
Recruiting
Phase 2
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
ObesityWeight LossObese+1 more
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics50 enrolled17 locationsNCT07400588
Recruiting
Phase 1Phase 2
Triple Hypoglycemic Regimens In Patients With Newly Diagnosed Type 2 Diabetes Mellitus
Type 2 Diabetes
Second Affiliated Hospital of Guangzhou Medical University240 enrolled1 locationNCT07374328
Recruiting
Phase 2
A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
T2DM (Type 2 Diabetes Mellitus)
Ascletis Pharma (China) Co., Limited100 enrolled8 locationsNCT07321678
Recruiting
Phase 2
The Effect of Glycemic Control and of GLP-1 Receptor Agonism on Islet GLP-1 in People With Type 1 and Type 2 Diabetes
Type 1 DiabetesType 2 Diabetes
Mayo Clinic60 enrolled1 locationNCT06976619
Recruiting
Phase 2
Food Effect, Efficacy and Safety of MKP10241 in Healthy and Obese Adult Participants, With and Without Diabetes
ObesityType 2 Diabetes Mellitus (T2DM)Food Effect+1 more
Mankind Pharma Limited68 enrolled1 locationNCT07098663
Recruiting
Phase 2
A Study of HDM1005 in Participants With T2DM Not Controlled With Diet/Exercise or Metformin
Type 2 Diabetes
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.216 enrolled1 locationNCT07109700
Recruiting
Phase 2
Renal Mechanism of SGLT2 Inhibition
Type 2 DiabetesDiabetic Kidney Disease
University of Colorado, Denver40 enrolled2 locationsNCT05507892
Recruiting
Phase 1Phase 2
Polypill for Prevention of Cardiomyopathy
Type 2 DiabetesHigh Blood Pressure
University of Texas Southwestern Medical Center200 enrolled1 locationNCT06143566
Recruiting
Phase 2
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
Type 2 Diabetes Mellitus (T2DM)Type 1 Diabetes MellitusDiabetic Foot Ulcer+3 more
Estar Medical dba Medical Technologies, LTD30 enrolled2 locationsNCT06810726
Recruiting
Phase 2
Finerenone Treatment for Diabetic Cardiovascular Autonomic Neuropathy: the FibroCAN Study
Type 2 DiabetesDiabetic NeuropathiesCardiovascular Autonomic Neuropathy
Peter Rossing100 enrolled2 locationsNCT06906081
Recruiting
Phase 2
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
Non-Alcoholic Fatty Liver DiseaseImpaired Glucose ToleranceType 2 Diabetes Mellitus+1 more
Yale University60 enrolled1 locationNCT05067621
Recruiting
Phase 2
Low-Dose Pioglitazone in Patients With NASH (AIM 2)
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Steatohepatitis
University of Florida166 enrolled1 locationNCT04501406
Recruiting
Phase 2
Regulation of Endogenous Glucose Production by Central KATP Channels
Glucose, High BloodType 2 Diabetes MellitusGlucose Metabolism Disorders
Meredith Hawkins100 enrolled1 locationNCT03540758
Recruiting
Phase 2
Safety and Efficacy of OCN19-overexpressed Human Umbilical Cord-derived Mesenchymal Stem Cells in the Treatment of Refractory Type 2 Diabetes Mellitus
DiabetesType 2 Diabetes
Lu jin ，MD10 enrolled1 locationNCT06727721
Recruiting
Phase 2
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
Type 2 Diabetes Mellitus (T2DM)
Hyundai Pharm160 enrolled1 locationNCT06647550